Gęca, K.;                     Litwiński, J.;                     Ostrowski, T.;                     Świetlicka, I.;                     Polkowski, W.P.;                     Skórzewska, M.    
        Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Cancers 2024, 16, 2150.
    https://doi.org/10.3390/cancers16112150
    AMA Style
    
                                Gęca K,                                 Litwiński J,                                 Ostrowski T,                                 Świetlicka I,                                 Polkowski WP,                                 Skórzewska M.        
                Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Cancers. 2024; 16(11):2150.
        https://doi.org/10.3390/cancers16112150
    
    Chicago/Turabian Style
    
                                Gęca, Katarzyna,                                 Jakub Litwiński,                                 Tomasz Ostrowski,                                 Izabela Świetlicka,                                 Wojciech P. Polkowski,                                 and Magdalena Skórzewska.        
                2024. "Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy" Cancers 16, no. 11: 2150.
        https://doi.org/10.3390/cancers16112150
    
    APA Style
    
                                Gęca, K.,                                 Litwiński, J.,                                 Ostrowski, T.,                                 Świetlicka, I.,                                 Polkowski, W. P.,                                 & Skórzewska, M.        
        
        (2024). Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Cancers, 16(11), 2150.
        https://doi.org/10.3390/cancers16112150